nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CYP3A4—Imiquimod—skin cancer	0.0735	0.233	CbGbCtD
Galantamine—CYP3A4—Temozolomide—skin cancer	0.0735	0.233	CbGbCtD
Galantamine—CYP2D6—Vemurafenib—skin cancer	0.0633	0.201	CbGbCtD
Galantamine—CYP3A4—Vismodegib—skin cancer	0.0509	0.162	CbGbCtD
Galantamine—CYP3A4—Vemurafenib—skin cancer	0.0403	0.128	CbGbCtD
Galantamine—CHRNA10—ear—skin cancer	0.0232	0.131	CbGeAlD
Galantamine—CYP3A4—Docetaxel—skin cancer	0.0138	0.0438	CbGbCtD
Galantamine—CHRNA3—skin epidermis—skin cancer	0.012	0.0676	CbGeAlD
Galantamine—CHRNA9—mammalian vulva—skin cancer	0.011	0.062	CbGeAlD
Galantamine—CHRNG—nipple—skin cancer	0.00978	0.0553	CbGeAlD
Galantamine—CHRNA7—skin epidermis—skin cancer	0.00781	0.0441	CbGeAlD
Galantamine—CHRNA6—skin of body—skin cancer	0.00665	0.0376	CbGeAlD
Galantamine—CHRNA4—nerve—skin cancer	0.00656	0.0371	CbGeAlD
Galantamine—CHRNB2—nipple—skin cancer	0.00596	0.0337	CbGeAlD
Galantamine—CHRNA5—head—skin cancer	0.00572	0.0324	CbGeAlD
Galantamine—CHRNB3—head—skin cancer	0.0052	0.0294	CbGeAlD
Galantamine—CHRNA6—head—skin cancer	0.00434	0.0245	CbGeAlD
Galantamine—CHRNA10—lymphoid tissue—skin cancer	0.0043	0.0243	CbGeAlD
Galantamine—CHRNG—head—skin cancer	0.00409	0.0231	CbGeAlD
Galantamine—CHRNA5—lymph node—skin cancer	0.00401	0.0227	CbGeAlD
Galantamine—CHRNB4—head—skin cancer	0.00394	0.0223	CbGeAlD
Galantamine—CHRNA7—neck—skin cancer	0.00374	0.0211	CbGeAlD
Galantamine—CHRNA3—skin of body—skin cancer	0.0037	0.0209	CbGeAlD
Galantamine—CHRNB2—mammalian vulva—skin cancer	0.00348	0.0197	CbGeAlD
Galantamine—CHRNA10—head—skin cancer	0.00347	0.0196	CbGeAlD
Galantamine—CHRNA1—lymphoid tissue—skin cancer	0.00336	0.019	CbGeAlD
Galantamine—CHRNA3—lymphoid tissue—skin cancer	0.003	0.017	CbGeAlD
Galantamine—CHRNA1—head—skin cancer	0.00271	0.0153	CbGeAlD
Galantamine—CHRNB2—head—skin cancer	0.00249	0.0141	CbGeAlD
Galantamine—CHRNA10—lymph node—skin cancer	0.00243	0.0137	CbGeAlD
Galantamine—CHRNA7—skin of body—skin cancer	0.00242	0.0137	CbGeAlD
Galantamine—CHRNA3—head—skin cancer	0.00242	0.0137	CbGeAlD
Galantamine—CHRFAM7A—female reproductive system—skin cancer	0.00234	0.0132	CbGeAlD
Galantamine—CHRNA2—head—skin cancer	0.00225	0.0127	CbGeAlD
Galantamine—BCHE—nipple—skin cancer	0.00213	0.0121	CbGeAlD
Galantamine—CHRNB1—head—skin cancer	0.00209	0.0118	CbGeAlD
Galantamine—CHRFAM7A—head—skin cancer	0.00195	0.011	CbGeAlD
Galantamine—CHRNA7—female reproductive system—skin cancer	0.00189	0.0107	CbGeAlD
Galantamine—CHRNB2—lymph node—skin cancer	0.00174	0.00986	CbGeAlD
Galantamine—CHRNA3—lymph node—skin cancer	0.00169	0.00957	CbGeAlD
Galantamine—CHRNA7—head—skin cancer	0.00158	0.00892	CbGeAlD
Galantamine—CHRNA4—head—skin cancer	0.00156	0.0088	CbGeAlD
Galantamine—CHRNB1—lymph node—skin cancer	0.00146	0.00828	CbGeAlD
Galantamine—BCHE—skin of body—skin cancer	0.00136	0.00772	CbGeAlD
Galantamine—ACHE—lymph node—skin cancer	0.00127	0.00717	CbGeAlD
Galantamine—BCHE—mammalian vulva—skin cancer	0.00124	0.00704	CbGeAlD
Galantamine—BCHE—female reproductive system—skin cancer	0.00107	0.00603	CbGeAlD
Galantamine—Somnolence—Imiquimod—skin cancer	0.000943	0.00186	CcSEcCtD
Galantamine—Hepatobiliary disease—Temozolomide—skin cancer	0.000942	0.00186	CcSEcCtD
Galantamine—Dyspepsia—Imiquimod—skin cancer	0.000933	0.00184	CcSEcCtD
Galantamine—Pneumonia—Fluorouracil—skin cancer	0.000923	0.00182	CcSEcCtD
Galantamine—Decreased appetite—Imiquimod—skin cancer	0.000922	0.00182	CcSEcCtD
Galantamine—Flushing—Dactinomycin—skin cancer	0.000918	0.00181	CcSEcCtD
Galantamine—Hypersensitivity—Vemurafenib—skin cancer	0.000916	0.0018	CcSEcCtD
Galantamine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000916	0.0018	CcSEcCtD
Galantamine—Fatigue—Imiquimod—skin cancer	0.000914	0.0018	CcSEcCtD
Galantamine—Atrial fibrillation—Docetaxel—skin cancer	0.000907	0.00179	CcSEcCtD
Galantamine—Renal impairment—Docetaxel—skin cancer	0.000904	0.00178	CcSEcCtD
Galantamine—Neuropathy peripheral—Fluorouracil—skin cancer	0.0009	0.00177	CcSEcCtD
Galantamine—Haemoglobin—Temozolomide—skin cancer	0.000899	0.00177	CcSEcCtD
Galantamine—Hepatitis—Temozolomide—skin cancer	0.000894	0.00176	CcSEcCtD
Galantamine—Haemorrhage—Temozolomide—skin cancer	0.000894	0.00176	CcSEcCtD
Galantamine—Urinary tract infection—Fluorouracil—skin cancer	0.000892	0.00176	CcSEcCtD
Galantamine—Asthenia—Vemurafenib—skin cancer	0.000892	0.00176	CcSEcCtD
Galantamine—BCHE—head—skin cancer	0.000891	0.00504	CbGeAlD
Galantamine—Hallucination—Temozolomide—skin cancer	0.00089	0.00175	CcSEcCtD
Galantamine—Urinary tract disorder—Temozolomide—skin cancer	0.000883	0.00174	CcSEcCtD
Galantamine—Oedema peripheral—Temozolomide—skin cancer	0.000881	0.00174	CcSEcCtD
Galantamine—Cardiac failure—Docetaxel—skin cancer	0.000881	0.00173	CcSEcCtD
Galantamine—Connective tissue disorder—Temozolomide—skin cancer	0.000879	0.00173	CcSEcCtD
Galantamine—Lethargy—Docetaxel—skin cancer	0.000877	0.00173	CcSEcCtD
Galantamine—Urethral disorder—Temozolomide—skin cancer	0.000877	0.00173	CcSEcCtD
Galantamine—Feeling abnormal—Imiquimod—skin cancer	0.000874	0.00172	CcSEcCtD
Galantamine—Gastrointestinal pain—Imiquimod—skin cancer	0.000867	0.00171	CcSEcCtD
Galantamine—Epistaxis—Fluorouracil—skin cancer	0.000866	0.00171	CcSEcCtD
Galantamine—Visual impairment—Temozolomide—skin cancer	0.000862	0.0017	CcSEcCtD
Galantamine—Pain in extremity—Docetaxel—skin cancer	0.00086	0.00169	CcSEcCtD
Galantamine—Ill-defined disorder—Bleomycin—skin cancer	0.000856	0.00169	CcSEcCtD
Galantamine—Anaemia—Bleomycin—skin cancer	0.000853	0.00168	CcSEcCtD
Galantamine—Diarrhoea—Vemurafenib—skin cancer	0.000851	0.00168	CcSEcCtD
Galantamine—Body temperature increased—Imiquimod—skin cancer	0.000838	0.00165	CcSEcCtD
Galantamine—Abdominal pain—Imiquimod—skin cancer	0.000838	0.00165	CcSEcCtD
Galantamine—Eye disorder—Temozolomide—skin cancer	0.000836	0.00165	CcSEcCtD
Galantamine—Tinnitus—Temozolomide—skin cancer	0.000834	0.00164	CcSEcCtD
Galantamine—Malaise—Bleomycin—skin cancer	0.000832	0.00164	CcSEcCtD
Galantamine—Flushing—Temozolomide—skin cancer	0.00083	0.00163	CcSEcCtD
Galantamine—Cardiac disorder—Temozolomide—skin cancer	0.00083	0.00163	CcSEcCtD
Galantamine—Haemoglobin—Fluorouracil—skin cancer	0.000828	0.00163	CcSEcCtD
Galantamine—Rhinitis—Fluorouracil—skin cancer	0.000826	0.00163	CcSEcCtD
Galantamine—Haemorrhage—Fluorouracil—skin cancer	0.000824	0.00162	CcSEcCtD
Galantamine—Dizziness—Vemurafenib—skin cancer	0.000822	0.00162	CcSEcCtD
Galantamine—Angiopathy—Temozolomide—skin cancer	0.000812	0.0016	CcSEcCtD
Galantamine—Ataxia—Docetaxel—skin cancer	0.000809	0.00159	CcSEcCtD
Galantamine—Immune system disorder—Temozolomide—skin cancer	0.000808	0.00159	CcSEcCtD
Galantamine—Cough—Bleomycin—skin cancer	0.000806	0.00159	CcSEcCtD
Galantamine—Dehydration—Docetaxel—skin cancer	0.0008	0.00157	CcSEcCtD
Galantamine—Ill-defined disorder—Dactinomycin—skin cancer	0.000799	0.00157	CcSEcCtD
Galantamine—Anaemia—Dactinomycin—skin cancer	0.000796	0.00157	CcSEcCtD
Galantamine—Vomiting—Vemurafenib—skin cancer	0.000791	0.00156	CcSEcCtD
Galantamine—Myalgia—Bleomycin—skin cancer	0.000786	0.00155	CcSEcCtD
Galantamine—Chest pain—Bleomycin—skin cancer	0.000786	0.00155	CcSEcCtD
Galantamine—Abdominal pain upper—Docetaxel—skin cancer	0.000785	0.00155	CcSEcCtD
Galantamine—Orthostatic hypotension—Docetaxel—skin cancer	0.000785	0.00155	CcSEcCtD
Galantamine—Rash—Vemurafenib—skin cancer	0.000784	0.00154	CcSEcCtD
Galantamine—Mental disorder—Temozolomide—skin cancer	0.000784	0.00154	CcSEcCtD
Galantamine—Dermatitis—Vemurafenib—skin cancer	0.000783	0.00154	CcSEcCtD
Galantamine—Hypersensitivity—Imiquimod—skin cancer	0.000781	0.00154	CcSEcCtD
Galantamine—Headache—Vemurafenib—skin cancer	0.000779	0.00153	CcSEcCtD
Galantamine—Malnutrition—Temozolomide—skin cancer	0.000779	0.00153	CcSEcCtD
Galantamine—Discomfort—Bleomycin—skin cancer	0.000776	0.00153	CcSEcCtD
Galantamine—Malaise—Dactinomycin—skin cancer	0.000776	0.00153	CcSEcCtD
Galantamine—Dysgeusia—Temozolomide—skin cancer	0.000763	0.0015	CcSEcCtD
Galantamine—Asthenia—Imiquimod—skin cancer	0.000761	0.0015	CcSEcCtD
Galantamine—Confusional state—Bleomycin—skin cancer	0.00076	0.0015	CcSEcCtD
Galantamine—Back pain—Temozolomide—skin cancer	0.000753	0.00148	CcSEcCtD
Galantamine—Dysphagia—Docetaxel—skin cancer	0.000743	0.00146	CcSEcCtD
Galantamine—Nausea—Vemurafenib—skin cancer	0.000739	0.00145	CcSEcCtD
Galantamine—Thrombocytopenia—Bleomycin—skin cancer	0.000738	0.00145	CcSEcCtD
Galantamine—Arrhythmia—Fluorouracil—skin cancer	0.000736	0.00145	CcSEcCtD
Galantamine—Vision blurred—Temozolomide—skin cancer	0.000734	0.00144	CcSEcCtD
Galantamine—Myalgia—Dactinomycin—skin cancer	0.000733	0.00144	CcSEcCtD
Galantamine—Tremor—Temozolomide—skin cancer	0.00073	0.00144	CcSEcCtD
Galantamine—Diarrhoea—Imiquimod—skin cancer	0.000726	0.00143	CcSEcCtD
Galantamine—Discomfort—Dactinomycin—skin cancer	0.000724	0.00143	CcSEcCtD
Galantamine—Ill-defined disorder—Temozolomide—skin cancer	0.000722	0.00142	CcSEcCtD
Galantamine—Anaemia—Temozolomide—skin cancer	0.00072	0.00142	CcSEcCtD
Galantamine—Anorexia—Bleomycin—skin cancer	0.000718	0.00141	CcSEcCtD
Galantamine—CYP3A4—female reproductive system—skin cancer	0.000718	0.00406	CbGeAlD
Galantamine—Agitation—Temozolomide—skin cancer	0.000716	0.00141	CcSEcCtD
Galantamine—CYP2D6—female reproductive system—skin cancer	0.000706	0.00399	CbGeAlD
Galantamine—Hypotension—Bleomycin—skin cancer	0.000704	0.00139	CcSEcCtD
Galantamine—Malaise—Temozolomide—skin cancer	0.000702	0.00138	CcSEcCtD
Galantamine—Dizziness—Imiquimod—skin cancer	0.000701	0.00138	CcSEcCtD
Galantamine—Vertigo—Temozolomide—skin cancer	0.0007	0.00138	CcSEcCtD
Galantamine—Palpitations—Temozolomide—skin cancer	0.000688	0.00135	CcSEcCtD
Galantamine—Thrombocytopenia—Dactinomycin—skin cancer	0.000688	0.00135	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000686	0.00135	CcSEcCtD
Galantamine—Cough—Temozolomide—skin cancer	0.000679	0.00134	CcSEcCtD
Galantamine—Paraesthesia—Bleomycin—skin cancer	0.000676	0.00133	CcSEcCtD
Galantamine—Vision blurred—Fluorouracil—skin cancer	0.000676	0.00133	CcSEcCtD
Galantamine—Convulsion—Temozolomide—skin cancer	0.000675	0.00133	CcSEcCtD
Galantamine—Vomiting—Imiquimod—skin cancer	0.000674	0.00133	CcSEcCtD
Galantamine—Weight decreased—Docetaxel—skin cancer	0.000672	0.00132	CcSEcCtD
Galantamine—Hypertension—Temozolomide—skin cancer	0.000672	0.00132	CcSEcCtD
Galantamine—Anorexia—Dactinomycin—skin cancer	0.00067	0.00132	CcSEcCtD
Galantamine—Rash—Imiquimod—skin cancer	0.000669	0.00132	CcSEcCtD
Galantamine—Dermatitis—Imiquimod—skin cancer	0.000668	0.00132	CcSEcCtD
Galantamine—Pneumonia—Docetaxel—skin cancer	0.000666	0.00131	CcSEcCtD
Galantamine—Headache—Imiquimod—skin cancer	0.000664	0.00131	CcSEcCtD
Galantamine—Anaemia—Fluorouracil—skin cancer	0.000663	0.00131	CcSEcCtD
Galantamine—Arthralgia—Temozolomide—skin cancer	0.000663	0.00131	CcSEcCtD
Galantamine—Myalgia—Temozolomide—skin cancer	0.000663	0.00131	CcSEcCtD
Galantamine—Anxiety—Temozolomide—skin cancer	0.000661	0.0013	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000658	0.0013	CcSEcCtD
Galantamine—Discomfort—Temozolomide—skin cancer	0.000655	0.00129	CcSEcCtD
Galantamine—Decreased appetite—Bleomycin—skin cancer	0.000655	0.00129	CcSEcCtD
Galantamine—Renal failure—Docetaxel—skin cancer	0.000651	0.00128	CcSEcCtD
Galantamine—Neuropathy peripheral—Docetaxel—skin cancer	0.00065	0.00128	CcSEcCtD
Galantamine—Dry mouth—Temozolomide—skin cancer	0.000648	0.00128	CcSEcCtD
Galantamine—Confusional state—Temozolomide—skin cancer	0.000641	0.00126	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00064	0.00126	CcSEcCtD
Galantamine—Nausea—Imiquimod—skin cancer	0.00063	0.00124	CcSEcCtD
Galantamine—Hepatobiliary disease—Docetaxel—skin cancer	0.000627	0.00123	CcSEcCtD
Galantamine—Epistaxis—Docetaxel—skin cancer	0.000625	0.00123	CcSEcCtD
Galantamine—BCHE—lymph node—skin cancer	0.000624	0.00353	CbGeAlD
Galantamine—Nervous system disorder—Temozolomide—skin cancer	0.000623	0.00123	CcSEcCtD
Galantamine—Thrombocytopenia—Temozolomide—skin cancer	0.000622	0.00123	CcSEcCtD
Galantamine—Convulsion—Fluorouracil—skin cancer	0.000622	0.00122	CcSEcCtD
Galantamine—Feeling abnormal—Bleomycin—skin cancer	0.000621	0.00122	CcSEcCtD
Galantamine—Skin disorder—Temozolomide—skin cancer	0.000617	0.00122	CcSEcCtD
Galantamine—Hyperhidrosis—Temozolomide—skin cancer	0.000614	0.00121	CcSEcCtD
Galantamine—Myalgia—Fluorouracil—skin cancer	0.000611	0.0012	CcSEcCtD
Galantamine—Chest pain—Fluorouracil—skin cancer	0.000611	0.0012	CcSEcCtD
Galantamine—Decreased appetite—Dactinomycin—skin cancer	0.000611	0.0012	CcSEcCtD
Galantamine—Fatigue—Dactinomycin—skin cancer	0.000606	0.00119	CcSEcCtD
Galantamine—Anorexia—Temozolomide—skin cancer	0.000606	0.00119	CcSEcCtD
Galantamine—Discomfort—Fluorouracil—skin cancer	0.000603	0.00119	CcSEcCtD
Galantamine—Haemoglobin—Docetaxel—skin cancer	0.000598	0.00118	CcSEcCtD
Galantamine—Rhinitis—Docetaxel—skin cancer	0.000596	0.00117	CcSEcCtD
Galantamine—Body temperature increased—Bleomycin—skin cancer	0.000596	0.00117	CcSEcCtD
Galantamine—Haemorrhage—Docetaxel—skin cancer	0.000595	0.00117	CcSEcCtD
Galantamine—Hepatitis—Docetaxel—skin cancer	0.000595	0.00117	CcSEcCtD
Galantamine—Confusional state—Fluorouracil—skin cancer	0.00059	0.00116	CcSEcCtD
Galantamine—CYP2D6—head—skin cancer	0.00059	0.00334	CbGeAlD
Galantamine—Urinary tract disorder—Docetaxel—skin cancer	0.000587	0.00116	CcSEcCtD
Galantamine—Oedema peripheral—Docetaxel—skin cancer	0.000586	0.00115	CcSEcCtD
Galantamine—Connective tissue disorder—Docetaxel—skin cancer	0.000585	0.00115	CcSEcCtD
Galantamine—Urethral disorder—Docetaxel—skin cancer	0.000583	0.00115	CcSEcCtD
Galantamine—Feeling abnormal—Dactinomycin—skin cancer	0.000579	0.00114	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000579	0.00114	CcSEcCtD
Galantamine—Insomnia—Temozolomide—skin cancer	0.000575	0.00113	CcSEcCtD
Galantamine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000575	0.00113	CcSEcCtD
Galantamine—Nervous system disorder—Fluorouracil—skin cancer	0.000574	0.00113	CcSEcCtD
Galantamine—Thrombocytopenia—Fluorouracil—skin cancer	0.000573	0.00113	CcSEcCtD
Galantamine—Visual impairment—Docetaxel—skin cancer	0.000573	0.00113	CcSEcCtD
Galantamine—Tachycardia—Fluorouracil—skin cancer	0.000571	0.00113	CcSEcCtD
Galantamine—Paraesthesia—Temozolomide—skin cancer	0.000571	0.00112	CcSEcCtD
Galantamine—Somnolence—Temozolomide—skin cancer	0.000565	0.00111	CcSEcCtD
Galantamine—Dyspepsia—Temozolomide—skin cancer	0.000559	0.0011	CcSEcCtD
Galantamine—Anorexia—Fluorouracil—skin cancer	0.000558	0.0011	CcSEcCtD
Galantamine—Eye disorder—Docetaxel—skin cancer	0.000556	0.00109	CcSEcCtD
Galantamine—Body temperature increased—Dactinomycin—skin cancer	0.000555	0.00109	CcSEcCtD
Galantamine—Abdominal pain—Dactinomycin—skin cancer	0.000555	0.00109	CcSEcCtD
Galantamine—Hypersensitivity—Bleomycin—skin cancer	0.000555	0.00109	CcSEcCtD
Galantamine—Decreased appetite—Temozolomide—skin cancer	0.000552	0.00109	CcSEcCtD
Galantamine—Flushing—Docetaxel—skin cancer	0.000552	0.00109	CcSEcCtD
Galantamine—Cardiac disorder—Docetaxel—skin cancer	0.000552	0.00109	CcSEcCtD
Galantamine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000549	0.00108	CcSEcCtD
Galantamine—Fatigue—Temozolomide—skin cancer	0.000548	0.00108	CcSEcCtD
Galantamine—Hypotension—Fluorouracil—skin cancer	0.000547	0.00108	CcSEcCtD
Galantamine—Constipation—Temozolomide—skin cancer	0.000543	0.00107	CcSEcCtD
Galantamine—Asthenia—Bleomycin—skin cancer	0.000541	0.00106	CcSEcCtD
Galantamine—Angiopathy—Docetaxel—skin cancer	0.00054	0.00106	CcSEcCtD
Galantamine—Immune system disorder—Docetaxel—skin cancer	0.000537	0.00106	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000533	0.00105	CcSEcCtD
Galantamine—Arrhythmia—Docetaxel—skin cancer	0.000531	0.00105	CcSEcCtD
Galantamine—Insomnia—Fluorouracil—skin cancer	0.00053	0.00104	CcSEcCtD
Galantamine—Paraesthesia—Fluorouracil—skin cancer	0.000526	0.00104	CcSEcCtD
Galantamine—Feeling abnormal—Temozolomide—skin cancer	0.000524	0.00103	CcSEcCtD
Galantamine—Mental disorder—Docetaxel—skin cancer	0.000521	0.00103	CcSEcCtD
Galantamine—Somnolence—Fluorouracil—skin cancer	0.000521	0.00102	CcSEcCtD
Galantamine—Gastrointestinal pain—Temozolomide—skin cancer	0.00052	0.00102	CcSEcCtD
Galantamine—Malnutrition—Docetaxel—skin cancer	0.000518	0.00102	CcSEcCtD
Galantamine—Hypersensitivity—Dactinomycin—skin cancer	0.000518	0.00102	CcSEcCtD
Galantamine—Dyspepsia—Fluorouracil—skin cancer	0.000515	0.00101	CcSEcCtD
Galantamine—Decreased appetite—Fluorouracil—skin cancer	0.000509	0.001	CcSEcCtD
Galantamine—Dysgeusia—Docetaxel—skin cancer	0.000507	0.000998	CcSEcCtD
Galantamine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000506	0.000995	CcSEcCtD
Galantamine—Asthenia—Dactinomycin—skin cancer	0.000504	0.000993	CcSEcCtD
Galantamine—Abdominal pain—Temozolomide—skin cancer	0.000502	0.000989	CcSEcCtD
Galantamine—Body temperature increased—Temozolomide—skin cancer	0.000502	0.000989	CcSEcCtD
Galantamine—Back pain—Docetaxel—skin cancer	0.000501	0.000986	CcSEcCtD
Galantamine—Muscle spasms—Docetaxel—skin cancer	0.000498	0.00098	CcSEcCtD
Galantamine—Feeling abnormal—Fluorouracil—skin cancer	0.000483	0.00095	CcSEcCtD
Galantamine—Diarrhoea—Dactinomycin—skin cancer	0.000481	0.000947	CcSEcCtD
Galantamine—Vomiting—Bleomycin—skin cancer	0.000479	0.000943	CcSEcCtD
Galantamine—Anaemia—Docetaxel—skin cancer	0.000479	0.000942	CcSEcCtD
Galantamine—Rash—Bleomycin—skin cancer	0.000475	0.000935	CcSEcCtD
Galantamine—Dermatitis—Bleomycin—skin cancer	0.000475	0.000934	CcSEcCtD
Galantamine—Hypersensitivity—Temozolomide—skin cancer	0.000468	0.000922	CcSEcCtD
Galantamine—Syncope—Docetaxel—skin cancer	0.000464	0.000914	CcSEcCtD
Galantamine—Body temperature increased—Fluorouracil—skin cancer	0.000463	0.000911	CcSEcCtD
Galantamine—Palpitations—Docetaxel—skin cancer	0.000458	0.000901	CcSEcCtD
Galantamine—Asthenia—Temozolomide—skin cancer	0.000456	0.000898	CcSEcCtD
Galantamine—Loss of consciousness—Docetaxel—skin cancer	0.000455	0.000896	CcSEcCtD
Galantamine—Cough—Docetaxel—skin cancer	0.000452	0.00089	CcSEcCtD
Galantamine—Convulsion—Docetaxel—skin cancer	0.000449	0.000883	CcSEcCtD
Galantamine—Nausea—Bleomycin—skin cancer	0.000447	0.000881	CcSEcCtD
Galantamine—Hypertension—Docetaxel—skin cancer	0.000447	0.00088	CcSEcCtD
Galantamine—Vomiting—Dactinomycin—skin cancer	0.000447	0.00088	CcSEcCtD
Galantamine—Rash—Dactinomycin—skin cancer	0.000443	0.000872	CcSEcCtD
Galantamine—Chest pain—Docetaxel—skin cancer	0.000441	0.000868	CcSEcCtD
Galantamine—Arthralgia—Docetaxel—skin cancer	0.000441	0.000868	CcSEcCtD
Galantamine—Myalgia—Docetaxel—skin cancer	0.000441	0.000868	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000438	0.000862	CcSEcCtD
Galantamine—Diarrhoea—Temozolomide—skin cancer	0.000435	0.000856	CcSEcCtD
Galantamine—Hypersensitivity—Fluorouracil—skin cancer	0.000431	0.000849	CcSEcCtD
Galantamine—Dry mouth—Docetaxel—skin cancer	0.000431	0.000849	CcSEcCtD
Galantamine—Confusional state—Docetaxel—skin cancer	0.000426	0.000839	CcSEcCtD
Galantamine—Dizziness—Temozolomide—skin cancer	0.00042	0.000827	CcSEcCtD
Galantamine—Nausea—Dactinomycin—skin cancer	0.000417	0.000822	CcSEcCtD
Galantamine—Shock—Docetaxel—skin cancer	0.000416	0.000819	CcSEcCtD
Galantamine—Nervous system disorder—Docetaxel—skin cancer	0.000414	0.000816	CcSEcCtD
Galantamine—Thrombocytopenia—Docetaxel—skin cancer	0.000414	0.000815	CcSEcCtD
Galantamine—Tachycardia—Docetaxel—skin cancer	0.000412	0.000812	CcSEcCtD
Galantamine—Skin disorder—Docetaxel—skin cancer	0.000411	0.000808	CcSEcCtD
Galantamine—Vomiting—Temozolomide—skin cancer	0.000404	0.000796	CcSEcCtD
Galantamine—Anorexia—Docetaxel—skin cancer	0.000403	0.000793	CcSEcCtD
Galantamine—Rash—Temozolomide—skin cancer	0.000401	0.000789	CcSEcCtD
Galantamine—Diarrhoea—Fluorouracil—skin cancer	0.000401	0.000789	CcSEcCtD
Galantamine—Dermatitis—Temozolomide—skin cancer	0.0004	0.000788	CcSEcCtD
Galantamine—Headache—Temozolomide—skin cancer	0.000398	0.000784	CcSEcCtD
Galantamine—Hypotension—Docetaxel—skin cancer	0.000395	0.000778	CcSEcCtD
Galantamine—Dizziness—Fluorouracil—skin cancer	0.000387	0.000762	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000385	0.000758	CcSEcCtD
Galantamine—Insomnia—Docetaxel—skin cancer	0.000382	0.000753	CcSEcCtD
Galantamine—Paraesthesia—Docetaxel—skin cancer	0.000379	0.000747	CcSEcCtD
Galantamine—Nausea—Temozolomide—skin cancer	0.000377	0.000743	CcSEcCtD
Galantamine—Somnolence—Docetaxel—skin cancer	0.000376	0.00074	CcSEcCtD
Galantamine—Vomiting—Fluorouracil—skin cancer	0.000372	0.000733	CcSEcCtD
Galantamine—Dyspepsia—Docetaxel—skin cancer	0.000372	0.000732	CcSEcCtD
Galantamine—Rash—Fluorouracil—skin cancer	0.000369	0.000727	CcSEcCtD
Galantamine—Dermatitis—Fluorouracil—skin cancer	0.000369	0.000726	CcSEcCtD
Galantamine—Decreased appetite—Docetaxel—skin cancer	0.000367	0.000723	CcSEcCtD
Galantamine—Headache—Fluorouracil—skin cancer	0.000367	0.000722	CcSEcCtD
Galantamine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000365	0.000718	CcSEcCtD
Galantamine—Fatigue—Docetaxel—skin cancer	0.000364	0.000717	CcSEcCtD
Galantamine—Constipation—Docetaxel—skin cancer	0.000361	0.000712	CcSEcCtD
Galantamine—Feeling abnormal—Docetaxel—skin cancer	0.000348	0.000686	CcSEcCtD
Galantamine—Nausea—Fluorouracil—skin cancer	0.000348	0.000685	CcSEcCtD
Galantamine—Gastrointestinal pain—Docetaxel—skin cancer	0.000346	0.00068	CcSEcCtD
Galantamine—Body temperature increased—Docetaxel—skin cancer	0.000334	0.000658	CcSEcCtD
Galantamine—Abdominal pain—Docetaxel—skin cancer	0.000334	0.000658	CcSEcCtD
Galantamine—Hypersensitivity—Docetaxel—skin cancer	0.000311	0.000613	CcSEcCtD
Galantamine—Asthenia—Docetaxel—skin cancer	0.000303	0.000597	CcSEcCtD
Galantamine—Diarrhoea—Docetaxel—skin cancer	0.000289	0.000569	CcSEcCtD
Galantamine—Dizziness—Docetaxel—skin cancer	0.000279	0.00055	CcSEcCtD
Galantamine—Vomiting—Docetaxel—skin cancer	0.000269	0.000529	CcSEcCtD
Galantamine—Rash—Docetaxel—skin cancer	0.000266	0.000525	CcSEcCtD
Galantamine—Dermatitis—Docetaxel—skin cancer	0.000266	0.000524	CcSEcCtD
Galantamine—Headache—Docetaxel—skin cancer	0.000265	0.000521	CcSEcCtD
Galantamine—Nausea—Docetaxel—skin cancer	0.000251	0.000494	CcSEcCtD
